SCHEMBL248648

SCHEMBL248648

CN(C)C1(c2cccs2)CCC(N)CC1.O=C(O)CCCC(=O)NCc1cc(Cl)ccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HPGD P15428 1/20 0.37
P2RX7 Q99572 4/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
POLB P06746 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRM1 P35372 3/20 0.34
OPRL1 P41146 3/20 0.34
KMT2A Q03164 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249977 0.88 SMN1; SMN2 (0.46) NPC1RAB9AHPGDP2RX7SMN1; SMN2
SCHEMBL248430 0.82 THRB (0.37) P2RX7LMNAPOLBHTTSMN1; SMN2
SCHEMBL249994 0.81 NPC1 (0.45) NPC1LMNAGAAHTTSMN1; SMN2
SCHEMBL250033 0.78 OPRL1 (0.42) NPC1RAB9AGAAOPRM1OPRL1
SCHEMBL250561 0.77 HDAC3 (0.39) LMNAPOLBSMN1; SMN2OPRM1OPRL1
SCHEMBL251283 0.76 OPRM1 (0.44) NPC1RAB9AHPGDGAAOPRM1
SCHEMBL4074080 0.76 OPRM1 (0.51) NPC1RAB9AOPRM1OPRL1EPHX2
SCHEMBL250442 0.75 MEN1 (0.42) RAB9ALMNAGAAKMT2A
SCHEMBL4074083 0.75 SMN1; SMN2 (0.52) RAB9AHPGDP2RX7GAAPOLB
SCHEMBL249743 0.75 CX3CR1 (0.44) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed